Concepedia

Author

J. Lecomte

Institut Jules Bordet

Also Known As

J J Lafitte, J LECOMTE, J Lecomte, J. LECOMTE, J. Lecomte, Lecomte, J., M Paesmans,  T Berghmans

130

Publications

1.2K

Citations

19

H-Index

21

Concepts

All Affiliations

Institut Jules BordetCentre Hospitalier Universitaire de Saint-PierreGrand Charleroi HospitalHospital de SaguntoClinique Saint-Joseph
JL

About

J. Lecomte is an author at Institut Jules Bordet specializing in oncology, lung cancer, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

12

453

2

Health Sciences

9

9

345

3

Pharmacology

3

3

111

4

Social Sciences

1

1

53

5

Pathology

1

1

131

J. Lecomte

×

18

Publications

866

Citations

17

H-Index

YearCitations

Prognostic factors for patients with small cell lung carcinoma

Marianne Paesmans, Jean‐Paul Sculier, J. Lecomte,

Cancer

2000

220

Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.

Jean Klášterský, Jean‐Paul Sculier, G. Bureau,

Journal of Clinical Oncology

1989

131

Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.

Jean‐Paul Sculier, M Paesmans, G. Bureau,

Journal of Clinical Oncology

1996

72

[The common chemical sense].

J. Lecomte

PubMed

1963

53

A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer

J.P. Sculier, J.J. Lafitte, T. Berghmans,

Lung Cancer

2000

51

A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer

Jean‐Paul Sculier, J.J. Lafitte, J. Lecomte,

Annals of Oncology

2002

44

Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC)

Marcela Maria Fontes Borges, Jean‐Paul Sculier, Marianne Paesmans,

Lung Cancer

1996

31

Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.

Sculier Jp, Marianne Paesmans, J Thiriaux,

Journal of Clinical Oncology

1998

30

A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer

J.P. Sculier, Marianne Paesmans, J Thiriaux,

European Journal of Cancer

1999

29

Chemotherapy improves low performance status lung cancer patients

Jean‐Paul Sculier, J.J. Lafitte, Marianne Paesmans,

European Respiratory Journal

2007

28

Page 1